Vault-13

UNIVERSITY OF CHICAGO

CHICAGO, IL · CIK 314957 · 13F filing filed 2024-07-15

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$129.7m reported value +87.2% vs Q1 2024
7positions
100.0%in top 10
1 new 3 added 0 reduced 1 sold out vs Q1 2024

Holdings, Q2 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 VANGUARD BD INDEX FDS TOTAL BND MRKT BND BND 766,763 $55.2m42.59% 42.59% AddedShares held: Q3 2023 706.5k, Q4 2023 706.5k, Q1 2024 729.0k, Q2 2024 766.8k +37.8k +37,775 5.2%
2 VANGUARD INTL EQUITY INDEX F TT WRLD ST ETF VT VT 335,471 $37.8m29.13% 29.13% AddedShares held: Q3 2023 81.2k, Q4 2023 81.2k, Q1 2024 60.8k, Q2 2024 335.5k +274.7k +274,652 451.6%
3 VANGUARD INDEX FDS S&P 500 ETF SHS VOO VOO 68,413 $34.3m26.47% 26.47% AddedShares held: Q3 2023 56.0k, Q4 2023 17.9k, Q1 2024 16.3k, Q2 2024 68.4k +52.1k +52,143 320.5%
4 ABBVIE INC COM ABBV ABBV 6,000 $1.0m0.79% 0.79% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 6.0k
5 NKGEN BIOTECH INC COM NKGN NKGN 550,000 $698.5k0.54% 0.54% UnchangedShares held: Q3 2023 0, Q4 2023 550.0k, Q1 2024 550.0k, Q2 2024 550.0k
6 OVINTIV INC COM OVV OVV 10,000 $468.7k0.36% 0.36% UnchangedShares held: Q3 2023 0, Q4 2023 10.0k, Q1 2024 10.0k, Q2 2024 10.0k
7 PYXIS ONCOLOGY INC COMMON STOCK PYXS PYXS 48,731 $161.3k0.12% 0.12% UnchangedShares held: Q3 2023 48.7k, Q4 2023 48.7k, Q1 2024 48.7k, Q2 2024 48.7k

Sold out since Q1 2024

SecurityTickerShares held beforeValue then
ADTALEM GLOBAL ED INC CVSA CVSA 1,040 $53.5k1.0k shares